Our diverse team members bring with them extensive work experience and expertise in their respective fields. We are dedicated to innovating non-invasive clinical applications for early detection of cancer. We are committed to rigorous testing, data-driven processing, accurate unbiased reporting, and to engineer highly accurate and reliable diagnostic tools. Our goal is to make a significant impact on improving the survivability of cancer.

Thomas Long

Cherylle Goebel

Christopher Louden

Dorothy Wong, MD, JD

Gerald Weiss, MD

Jyothsna Narla, MD
About Us

Jerry Hurst, MA, CLS, CPHM

Michael Kalinger, CLS, MLS(ASCP)CM

Rachel Chuang, PhD

Nancy Lim, PharmD
Scientific Advisory Board

Dr. Robert McKenna, Jr., MD

Dr. Andrew Wachtel, MD

Cherylle Goebel
